Karl Rickels, MD, MD | Psychiatrist.com

Original Research

Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial

September 15, 2006

Alan D. Feiger, MD, Karl Rickels, MD, Moira A. Rynn, MD, et al